Erectile Dysfunction Treatment Using Stem Cells

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 10, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

December 30, 2024

Conditions
Erectile Dysfunction
Interventions
COMBINATION_PRODUCT

UC-MSCs and PRP

UC-MSCs are progenitor cells that can differentiate into various types of cells in the body and have the ability to regenerate and repair damaged tissue. During repair and regeneration, these cells secrete expedient and powerful bioactive paracrine factors including cytokines, chemokines, collagen, fibronectin, and growth factors promoting tissue repair, angiogenesis, and the regeneration of nerve cells as well as regulating cellular pathways including immunomodulation and inflammatory responses. Additionally, PRP contains numerous growth factors and cytokines, including vascular endothelial growth factor (VEGF), transforming growth factor beta-1 and beta-2 (TGF-β1/2), platelet-derived growth factor (PDGF), insulin-like growth factor (IGF), interleukin 8 and matrix metalloproteinases 2,9. The combined effect of these factors provided by PRP injections is proposed to have anti- inflammatory, reparative, neuroprotective and neurotrophic effects that contribute to the treatment of ED.

Trial Locations (1)

0000

COR clinic for Regenerative Medicine, Beirut

All Listed Sponsors
lead

COR clinic of Regenerative Medicine

NETWORK

NCT06550752 - Erectile Dysfunction Treatment Using Stem Cells | Biotech Hunter | Biotech Hunter